Reidun Kopperud

799 total citations
16 papers, 635 citations indexed

About

Reidun Kopperud is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Hematology. According to data from OpenAlex, Reidun Kopperud has authored 16 papers receiving a total of 635 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 3 papers in Cardiology and Cardiovascular Medicine and 3 papers in Hematology. Recurrent topics in Reidun Kopperud's work include Phosphodiesterase function and regulation (5 papers), Platelet Disorders and Treatments (3 papers) and Protein Kinase Regulation and GTPase Signaling (3 papers). Reidun Kopperud is often cited by papers focused on Phosphodiesterase function and regulation (5 papers), Platelet Disorders and Treatments (3 papers) and Protein Kinase Regulation and GTPase Signaling (3 papers). Reidun Kopperud collaborates with scholars based in Norway, Denmark and Spain. Reidun Kopperud's co-authors include Stein Ove Døskeland, Camilla Krakstad, Frode Selheim, Anne Elisabeth Christensen, Frank Schwede, Aurora Martı́nez, Knut Teigen, Erlend Hodneland, Khanh K. Dao and Karl‐Henning Kalland and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and Journal of Virology.

In The Last Decade

Reidun Kopperud

16 papers receiving 631 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Reidun Kopperud 427 82 59 57 54 16 635
Aleksander Baldys 336 0.8× 60 0.7× 53 0.9× 92 1.6× 104 1.9× 17 534
Sabine Uhles 345 0.8× 55 0.7× 70 1.2× 84 1.5× 71 1.3× 16 626
Anne Otten 302 0.7× 63 0.8× 82 1.4× 66 1.2× 35 0.6× 7 477
Anke Prinz 588 1.4× 104 1.3× 53 0.9× 61 1.1× 70 1.3× 17 665
Kelly A. Kaihara 381 0.9× 46 0.6× 68 1.2× 51 0.9× 38 0.7× 16 652
Robert Rehfuss 655 1.5× 120 1.5× 126 2.1× 104 1.8× 49 0.9× 25 1000
Louisa Dowal 391 0.9× 84 1.0× 21 0.4× 47 0.8× 139 2.6× 22 596
Cecilia Y. Cheng 624 1.5× 52 0.6× 34 0.6× 55 1.0× 85 1.6× 11 728
Katherine Marcelain 447 1.0× 62 0.8× 38 0.6× 124 2.2× 75 1.4× 50 847
Marco Schiavone 632 1.5× 58 0.7× 46 0.8× 46 0.8× 140 2.6× 32 797

Countries citing papers authored by Reidun Kopperud

Since Specialization
Citations

This map shows the geographic impact of Reidun Kopperud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reidun Kopperud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reidun Kopperud more than expected).

Fields of papers citing papers by Reidun Kopperud

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reidun Kopperud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reidun Kopperud. The network helps show where Reidun Kopperud may publish in the future.

Co-authorship network of co-authors of Reidun Kopperud

This figure shows the co-authorship network connecting the top 25 collaborators of Reidun Kopperud. A scholar is included among the top collaborators of Reidun Kopperud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reidun Kopperud. Reidun Kopperud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Kopperud, Reidun, Line Pedersen, B. van der Hoeven, et al.. (2020). Epac1 null mice have nephrogenic diabetes insipidus with deficient corticopapillary osmotic gradient and weaker collecting duct tight junctions. Acta Physiologica. 229(1). e13442–e13442. 7 indexed citations
2.
Majumder, Muntasir Mamun, Aino‐Maija Leppä, Monica Hellesøy, et al.. (2019). Multi-parametric single cell evaluation defines distinct drug responses in healthy hematologic cells that are retained in corresponding malignant cell types. Haematologica. 105(6). 1527–1538. 16 indexed citations
3.
Kopperud, Reidun, Erling A. Høivik, Reidun Aesöy, et al.. (2016). Long-term consumption of an obesogenic high fat diet prior to ischemia-reperfusion mediates cardioprotection via Epac1-dependent signaling. Nutrition & Metabolism. 13(1). 87–87. 18 indexed citations
4.
Tangen, Ingvild L., Reidun Kopperud, Anna Berg, et al.. (2016). Androgen receptor as potential therapeutic target in metastatic endometrial cancer. Oncotarget. 7(31). 49289–49298. 56 indexed citations
5.
Nygaard, Gyrid, Lars Herfindal, Reidun Kopperud, et al.. (2014). Time-dependent inhibitory effects of cGMP-analogues on thrombin-induced platelet-derived microparticles formation, platelet aggregation, and P-selectin expression. Biochemical and Biophysical Research Communications. 449(3). 357–363. 6 indexed citations
6.
Herfindal, Lars, Gyrid Nygaard, Reidun Kopperud, et al.. (2013). Off-target effect of the Epac agonist 8-pCPT-2′-O-Me-cAMP on P2Y12 receptors in blood platelets. Biochemical and Biophysical Research Communications. 437(4). 603–608. 16 indexed citations
7.
Karlsen, Tine V., et al.. (2012). Microvascular permeability in the absence of Epac1 activity. The FASEB Journal. 26(S1). 2 indexed citations
8.
Kleppe, Rune, Camilla Krakstad, Frode Selheim, Reidun Kopperud, & Stein Ove Døskeland. (2011). The cAMP-Dependent Protein Kinase Pathway as Therapeutic Target – Possibilities and Pitfalls. Current Topics in Medicinal Chemistry. 11(11). 1393–1405. 16 indexed citations
9.
Kleppe, Rune, Reidun Kopperud, Gyrid Nygaard, et al.. (2010). Dipyridamole synergizes with nitric oxide to prolong inhibition of thrombin-induced platelet shape change. Platelets. 22(1). 7–18. 9 indexed citations
10.
Arntzen, Magnus Ø., et al.. (2009). POSTMan (POST‐translational modification analysis), a software application for PTM discovery. PROTEOMICS. 9(5). 1400–1406. 3 indexed citations
11.
Dao, Khanh K., Knut Teigen, Reidun Kopperud, et al.. (2006). Epac1 and cAMP-dependent Protein Kinase Holoenzyme Have Similar cAMP Affinity, but Their cAMP Domains Have Distinct Structural Features and Cyclic Nucleotide Recognition. Journal of Biological Chemistry. 281(30). 21500–21511. 121 indexed citations
12.
Kopperud, Reidun, Camilla Krakstad, Frode Selheim, & Stein Ove Døskeland. (2003). cAMP effector mechanisms. Novel twists for an ‘old’ signaling system. FEBS Letters. 546(1). 121–126. 169 indexed citations
13.
Dremier, Sarah, Reidun Kopperud, Stein Ove Døskeland, J.E. Dumont, & Carine Maenhaut. (2003). Search for new cyclic AMP‐binding proteins. FEBS Letters. 546(1). 103–107. 63 indexed citations
14.
Kopperud, Reidun, et al.. (2002). Formation of Inactive cAMP-saturated Holoenzyme of cAMP-dependent Protein Kinase under Physiological Conditions. Journal of Biological Chemistry. 277(16). 13443–13448. 53 indexed citations
16.
Szilvay, Anne Marie, Karl A. Brokstad, Reidun Kopperud, Gunnar Haukenes, & Karl‐Henning Kalland. (1995). Nuclear export of the human immunodeficiency virus type 1 nucleocytoplasmic shuttle protein Rev is mediated by its activation domain and is blocked by transdominant negative mutants. Journal of Virology. 69(6). 3315–3323. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026